Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Pirenzepine is an antagonist of M1 muscarinic acetylcholine receptors (Ki = 11.48 nM).1 It is selective for M1 over M2, M3, and M4 receptors (Kis = 602.56, 151.36, and 199.53 nM, respectively). Pirenzepine inhibits ascending reflex contraction of the circular smooth muscle in isolated guinea pig ileal segments induced by intraluminal balloon inflation (IC50 = 501.19 nM). It inhibits methacholine-induced increases in ileal pressure in guinea pigs (ID50 = 724.44 nmol/kg). Pirenzepine inhibits oxotremorine-induced gastric ulcer, gastric acid secretion, and salivation in rats (ED50s = 13, 37.5, and 620 μg/kg i.v., respectively).2 It prevents form-deprivation myopia (FDM) in a chick model of experimental myopia.3
WARNING This product is not for human or veterinary use.
1. Pharmacological profile of selective muscarinic receptor antagonists on guinea-
2. Pharmacodynamic evaluation of selective antimuscarinic properties of pirenzepine in the rat. Pharmacol. Res. Commun. 14(3), 279-287 (1982).
3. Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. Invest. Ophthalmol. Vis. Sci. 44(3), 1330-1338 (2003).